Berlin-based Aignostics Secures €31.4 Million Series B Funding

In a significant stride for precision medicine, Aignostics, a pioneering artificial intelligence company, has announced the successful closure of a €31.4 million Series B funding round. This substantial investment underscores the growing reliance on AI to revolutionize the field of computational pathology.

The funding round, oversubscribed and led by ATHOS, also saw participation from prominent entities such as Mayo Clinic and HTGF, alongside existing investors like Wellington Partners and Boehringer Ingelheim Venture Fund. This brings Aignostics’ total funding to over $55 million, a testament to the confidence investors have in its cutting-edge AI models and strategic vision.

“At its core, Aignostics is a world-class machine learning company,” stated Julian Zachmann from ATHOS. “The field is advancing so quickly that, in order to succeed, AI companies need to avoid flashy distractions, stay laser-focused on the highest-quality science, and relentlessly innovate. Aignostics is doing just that.”

Strategic Partnerships and Innovations

Aignostics’ collaborations with esteemed institutions like Mayo Clinic are pivotal in developing foundational models for pathology. Jim Rogers, CEO of Mayo Clinic Digital Pathology, emphasized the potential impact of digital pathology paired with AI on patient diagnosis and treatment.

The new funding will bolster Aignostics’ offerings in target identification, translational research, and companion diagnostics (CDx). Viktor Matyas, CEO and Co-Founder of Aignostics, highlighted the launch of their first foundation model, RudolfV, as a key development. “With RudolfV, we’ve gained the ability to quickly develop cost-efficient algorithms that generalize to the real world,” he noted.

Future Prospects and Market Impact

As the landscape of precision medicine becomes increasingly complex, Aignostics is poised to lead the charge in integrating AI into biopharmaceutical research and diagnostics. The company’s strategic initiatives, including a major collaboration with Bayer, are set to propel its growth trajectory, particularly within the United States.

Niels Sharman, Senior Investment Manager at HTGF, expressed enthusiasm for Aignostics’ progress, stating, “We have been thoroughly impressed by Aignostics’ progress and their cutting-edge AI platform, which we believe will have a transformative impact on Pharma R&D.”

For more insights into Aignostics’ journey and strategic collaborations, refer to the original article on EU-Startups.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Tipping Point: How Artificial Intelligence Is Rewriting the Real Estate Playbook

Artificial intelligence has shifted from a novelty to a defining force in real estate, transforming everything from listing creation to virtual staging while raising new legal and ethical risks. As AI adoption accelerates, experts warn that the agents who embrace automation and new tools now will gain a major competitive edge, while those who delay could fall behind in a rapidly evolving industry.

Want Job Security in the Age of AI? Get a State License

As AI and automation reshape the workforce, one form of career protection remains as powerful as ever: earning a state license. From real estate to trades to finance, licensed professionals stay in high demand because their work requires proven competence, accountability and human judgment—qualities technology can enhance but never replace. With trade enrollment surging, investor interest growing and licensing on the rise across the country, credentials have become a reliable path to stability, mobility and long-term earning potential.

AI Tools Are Transforming Agent‑Buyer Connections Ahead of 2026

A new wave of AI platforms is redefining how real estate agents identify buyer intent, spark conversations, and nurture relationships. From conversational home search engines to predictive opportunity alerts and relationship‑intelligence systems, these tools are helping agents connect sooner and smarter—reshaping daily workflows as the 2026 market approaches.

Texas Investors Fuel San Francisco’s Real Estate Revival

Texas money is riding hard into San Francisco, snapping up distressed downtown buildings at prices not seen in decades. From Union Square to California Street, major players like Lone Star Funds are betting big on the city’s rebound, signaling that the market may have finally hit bottom and that a new wave of opportunity is taking shape for savvy real estate professionals nationwide.

Holiday Spending Hits $1 Trillion—But CRE Experts Warn It May Be an Illusion

The 2025 holiday season is expected to break the $1 trillion sales mark, but economists say the milestone masks deeper consumer caution, income‑driven spending gaps, and weakening unit sales. Urban Land Magazine’s latest analysis shows how these mixed signals are shaping a selective, uneven landscape for U.S. commercial real estate heading into 2026—where strong locations thrive, weaker assets struggle, and affluent shoppers continue to dictate market performance.

Housing Market Predictions for 2026: Are Home Prices Finally Ready to Cool Off?

As 2025 ends, the housing market is inching toward balance with slower price growth, rising inventory, and steadier mortgage rates. Experts predict modest 1% to 2% home‑price growth in 2026—not a crash, but a calmer, more predictable market shaped by regional differences. With the Fed easing rates and inventory climbing in key cities, 2026 may become the most buyer‑friendly year in recent memory, especially for those prepared to act when the right home appears.